Substituted aminopyridine compounds as EGFR inhibitors

The present invention provides novel aminopyridine compounds and pharmaceutically acceptable compositions thereof, which exhibit inhibitory activity against certain mutant forms of EGFR. 本发明提供了新的氨基吡啶化合物及其药学上可接受的组合物，其表现出针对某些突变形式的EGFR的抑制活性。...

Full description

Saved in:
Bibliographic Details
Main Authors BRYAN MARIAN C, PARK SOL, KIM TAE-GYUN, SIM JAE-YOUNG, KIM MI-SONG, LI BINGWEN, CHOI SU BIN, KUDUK SCOTT, LEE HYUN-JOO, KIM HEE-JUNE, YOON YOUNG-AE, LEE KYU-JIN, HYUN KWAN-HUN, ROBERTSON JAMES CAMPBELL
Format Patent
LanguageChinese
English
Published 03.05.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides novel aminopyridine compounds and pharmaceutically acceptable compositions thereof, which exhibit inhibitory activity against certain mutant forms of EGFR. 本发明提供了新的氨基吡啶化合物及其药学上可接受的组合物，其表现出针对某些突变形式的EGFR的抑制活性。
Bibliography:Application Number: CN202280062421